{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:17:04Z","timestamp":1746159424994,"version":"3.40.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.7759\/cureus.83319","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T23:24:27Z","timestamp":1746141867000},"source":"Crossref","is-referenced-by-count":0,"title":["Oral Steroid Pulse Therapy for Polymyalgia Rheumatica"],"prefix":"10.7759","author":[{"given":"Shigeko","family":"Inokuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Miike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Motoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.20008","article-title":"Polymyalgia rheumatica: an updated review","volume":"87","author":"Mahmood SB","year":"2020","unstructured":"Mahmood SB, Nelson E, Padniewski J, Nasr R. Polymyalgia rheumatica: an updated review. Cleve Clin J Med. 2020, 87:549-56. 10.3949\/ccjm.87a.20008","journal-title":"Cleve Clin J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma A","year":"2020","unstructured":"Sharma A, Mohammad AJ, Turesson C. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum. 2020, 50:1040-8. 10.1016\/j.semarthrit.2020.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32381-9","article-title":"Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble","volume":"389","author":"Kontis V","year":"2017","unstructured":"Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017, 389:1323-35. 10.1016\/S0140-6736(16)32381-9","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.22777","article-title":"Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica","volume":"57","author":"Hutchings A","year":"2007","unstructured":"Hutchings A, Hollywood J, Lamping DL, et al.. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum. 2007, 57:803-9. 10.1002\/art.22777","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00290-3","article-title":"Treatment patterns, disease burden, and outcomes in patients with giant cell arteritis and polymyalgia rheumatica: a real-world, electronic health record-based study of patients in clinical practice","volume":"8","author":"Craig G","year":"2021","unstructured":"Craig G, Knapp K, Salim B, Mohan SV, Michalska M. Treatment patterns, disease burden, and outcomes in patients with giant cell arteritis and polymyalgia rheumatica: a real-world, electronic health record-based study of patients in clinical practice. Rheumatol Ther. 2021, 8:529-39. 10.1007\/s40744-021-00290-3","journal-title":"Rheumatol Ther"},{"key":"ref6","article-title":"Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids","volume":"26","author":"Cimmino MA","year":"2008","unstructured":"Cimmino MA, Salvarani C, Macchioni P, Gerli R, Bartoloni Bocci E, Montecucco C, Caporali R. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheumatol. 2008, 26:395-400.","journal-title":"Clin Exp Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta B","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H, et al.. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012, 71:484-92. 10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco C","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P, et al.. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015, 74:1799-807. 10.1136\/annrheumdis-2015-207492","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110851","article-title":"Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study","volume":"39","author":"Mazzantini M","year":"2012","unstructured":"Mazzantini M, Torre C, Miccoli M, Baggiani A, Talarico R, Bombardieri S, Di Munno O. Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. J Rheumatol. 2012, 39:552-7. 10.3899\/jrheum.110851","journal-title":"J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58778","article-title":"Ibuprofen would be the first-line nonsteroidal anti-inflammatory drug for polymyalgia rheumatica: a case series of five patients","volume":"16","author":"Inokuma S","year":"2024","unstructured":"Inokuma S, Okazaki T, Morishita H, Tsuji M, Goto Y. Ibuprofen would be the first-line nonsteroidal anti-inflammatory drug for polymyalgia rheumatica: a case series of five patients. Cureus. 2024, 16:58778. 10.7759\/cureus.58778","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.622225","article-title":"The use of glucocorticoids in lupus nephritis: new pathways for an old drug","volume":"8","author":"Mej\u00eda-Vilet JM","year":"2021","unstructured":"Mej\u00eda-Vilet JM, Ayoub I. The use of glucocorticoids in lupus nephritis: new pathways for an old drug. Front Med (Lausanne). 2021, 8:622225. 10.3389\/fmed.2021.622225","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1890032","article-title":"Predicting the risk of relapse in polymyalgia rheumatica: novel insights","volume":"17","author":"Prieto-Pe\u00f1a D","year":"2021","unstructured":"Prieto-Pe\u00f1a D, Casta\u00f1eda S, Atienza-Mateo B, Blanco R, Gonz\u00e1lez-Gay MA. Predicting the risk of relapse in polymyalgia rheumatica: novel insights. Expert Rev Clin Immunol. 2021, 17:225-32. 10.1080\/1744666X.2021.1890032","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343301-oral-steroid-pulse-therapy-for-polymyalgia-rheumatica","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T23:24:28Z","timestamp":1746141868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343301-oral-steroid-pulse-therapy-for-polymyalgia-rheumatica"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.83319","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}